Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Pouget

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC StudyEmmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Medical Physics|July 8, 2020
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup> Lu-DOTATATE for peptide receptor radionuclide therapyErick Mora-Ramirez, Lore Santoro, Emmanuelle Cassol, et al.
Molecular Therapy. Methods & Clinical Development|January 3, 2022
<i>In vivo</i> optogenetic stimulation of the primate retina activates the visual cortex after long-term transductionAntoine Chaffiol, Matthieu Provansal, Corentin Joffrois, et al.
Breast Cancer Research : BCR|February 8, 2011
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) miceMaha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, et al.
Plos One|August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212PbVincent Boudousq, Laure Bobyk, Muriel Busson, et al.
Vision Research|March 12, 2013
An internationally standardised antisaccade protocolChrystalina Antoniades, Ulrich Ettinger, Bertrand Gaymard, et al.
Pharmacology & Therapeutics|October 23, 2021
Therapeutic antibodies - natural and pathological barriers and strategies to overcome themYara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized MedicineKévin Hebert, Lore Santoro, Maeva Monnier, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 14, 2018
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC StudyEmmanuel Deshayes, Hélène de Forges, Julien Fraisse, et al.
Medical Physics|July 8, 2020
Comparison of commercial dosimetric software platforms in patients treated with <sup>177</sup> Lu-DOTATATE for peptide receptor radionuclide therapyErick Mora-Ramirez, Lore Santoro, Emmanuelle Cassol, et al.
Molecular Therapy. Methods & Clinical Development|January 3, 2022
<i>In vivo</i> optogenetic stimulation of the primate retina activates the visual cortex after long-term transductionAntoine Chaffiol, Matthieu Provansal, Corentin Joffrois, et al.
Breast Cancer Research : BCR|February 8, 2011
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) miceMaha Z Ladjemi, Thierry Chardes, Stephanie Corgnac, et al.
Plos One|August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212PbVincent Boudousq, Laure Bobyk, Muriel Busson, et al.
Vision Research|March 12, 2013
An internationally standardised antisaccade protocolChrystalina Antoniades, Ulrich Ettinger, Bertrand Gaymard, et al.
Pharmacology & Therapeutics|October 23, 2021
Therapeutic antibodies - natural and pathological barriers and strategies to overcome themYara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.
Pageof 16